Skip to content

opioid receptor and postoperative nausea and vomiting

118G genetic polymorphism and postoperative nausea and vomiting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000461
Enrollment
160
Registered
2012-06-25
Start date
2012-06-28
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Konkuk University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients undergoing local excision of breast with admission were enrolled. The patients were American Society of Anesthesiologists Patient Status (ASA PS) I. And the patient were excluded if they apply PCA(patient controlled analgesia).

Exclusion criteria

Exclusion criteria: 1) urgent or emergent case, 2) re-do case, 3) allergy to egg or soybean oil, 4) coronary artery disease, 5) cerebral vascular disease, 6) neurological deficits or psychiatric disorders, 7) history of drug abuse, 8) receiving current medications, 9) concurrent other surgery, 10) renal disease (serum creatinine > 2.0 mg/dL) and 11) severe hepatic disease.

Design outcomes

Primary

MeasureTime frame
postoperative nausea and vomiting

Secondary

MeasureTime frame
postoperative pain scale;mean blood pressure;total dose of phenylephrine;heart rate;bispectral index;total dose of ephedrine;total dose of atropine; total doses of propofol;total dose of remifentanil

Countries

Korea, Republic of

Contacts

Public ContactJoo Eun Kang

Konkuk University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026